Cargando…

Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study

Safflower injection (SI), a water-extract preparation from safflower (Carthamus tinctorius L.), has been widely used for the treatment of cardio-cerebrovascular diseases. This work aims to develop an approach for identifying PK markers of cardiovascular herbal medicines using SI as a case study. Fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Peiying, Ruan, Yijun, Zhong, Chenhui, Teng, Linglin, Ke, Liyuan, Yao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727182/
https://www.ncbi.nlm.nih.gov/pubmed/36506545
http://dx.doi.org/10.3389/fphar.2022.1062026
_version_ 1784844953576275968
author Shi, Peiying
Ruan, Yijun
Zhong, Chenhui
Teng, Linglin
Ke, Liyuan
Yao, Hong
author_facet Shi, Peiying
Ruan, Yijun
Zhong, Chenhui
Teng, Linglin
Ke, Liyuan
Yao, Hong
author_sort Shi, Peiying
collection PubMed
description Safflower injection (SI), a water-extract preparation from safflower (Carthamus tinctorius L.), has been widely used for the treatment of cardio-cerebrovascular diseases. This work aims to develop an approach for identifying PK markers of cardiovascular herbal medicines using SI as a case study. Firstly, qualitative and quantitative analyses were performed to reveal ingredients of the preparation via HPLC-MS. Subsequently, multiple PK ingredients and integrated PK investigations were carried out to ascertain ingredients with favorable PK properties (e.g., easily detected at conventional PK time points and high system exposure) for the whole preparation. Next, ingredients against cardiovascular diseases (CVDs) in the preparation were predicted with target fishing and system pharmacology studies. Finally, ingredients with favorable PK properties, satisfactory PK representativeness for the preparation, and high relevance to CVDs were considered as potential PK markers. Their therapeutic effect was further evaluated using the H(2)O(2)-induced H9c2 cardiomyocyte-injured model and a proteomics study to identify objective PK markers. As results, it disclosed that SI mainly contains 11 ingredients. Among them, five ingredients, namely, hydroxysafflor yellow A (HSYA), syringin (SYR), p-coumaric acid (p-CA), scutellarin (SCU), and p-hydroxybenzaldehyde (p-HBA), showed favorable PK properties. HSYA, SYR, and rutin (RU) were predicted to show high relevance to CVDs and screened as potential PK markers. However, only HSYA and SYR were confirmed as therapeutic ingredients against CVDs. Combined with these findings, only HSYA demonstrated satisfactory representativeness on PK properties and therapeutic effects of multiple ingredients of the preparation, thereby indicating that HSYA is a potential PK marker for the SI. The results of this study can provide a reference for the characterization of PK markers for traditional Chinese medicines.
format Online
Article
Text
id pubmed-9727182
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97271822022-12-08 Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study Shi, Peiying Ruan, Yijun Zhong, Chenhui Teng, Linglin Ke, Liyuan Yao, Hong Front Pharmacol Pharmacology Safflower injection (SI), a water-extract preparation from safflower (Carthamus tinctorius L.), has been widely used for the treatment of cardio-cerebrovascular diseases. This work aims to develop an approach for identifying PK markers of cardiovascular herbal medicines using SI as a case study. Firstly, qualitative and quantitative analyses were performed to reveal ingredients of the preparation via HPLC-MS. Subsequently, multiple PK ingredients and integrated PK investigations were carried out to ascertain ingredients with favorable PK properties (e.g., easily detected at conventional PK time points and high system exposure) for the whole preparation. Next, ingredients against cardiovascular diseases (CVDs) in the preparation were predicted with target fishing and system pharmacology studies. Finally, ingredients with favorable PK properties, satisfactory PK representativeness for the preparation, and high relevance to CVDs were considered as potential PK markers. Their therapeutic effect was further evaluated using the H(2)O(2)-induced H9c2 cardiomyocyte-injured model and a proteomics study to identify objective PK markers. As results, it disclosed that SI mainly contains 11 ingredients. Among them, five ingredients, namely, hydroxysafflor yellow A (HSYA), syringin (SYR), p-coumaric acid (p-CA), scutellarin (SCU), and p-hydroxybenzaldehyde (p-HBA), showed favorable PK properties. HSYA, SYR, and rutin (RU) were predicted to show high relevance to CVDs and screened as potential PK markers. However, only HSYA and SYR were confirmed as therapeutic ingredients against CVDs. Combined with these findings, only HSYA demonstrated satisfactory representativeness on PK properties and therapeutic effects of multiple ingredients of the preparation, thereby indicating that HSYA is a potential PK marker for the SI. The results of this study can provide a reference for the characterization of PK markers for traditional Chinese medicines. Frontiers Media S.A. 2022-11-23 /pmc/articles/PMC9727182/ /pubmed/36506545 http://dx.doi.org/10.3389/fphar.2022.1062026 Text en Copyright © 2022 Shi, Ruan, Zhong, Teng, Ke and Yao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shi, Peiying
Ruan, Yijun
Zhong, Chenhui
Teng, Linglin
Ke, Liyuan
Yao, Hong
Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
title Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
title_full Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
title_fullStr Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
title_full_unstemmed Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
title_short Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
title_sort identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727182/
https://www.ncbi.nlm.nih.gov/pubmed/36506545
http://dx.doi.org/10.3389/fphar.2022.1062026
work_keys_str_mv AT shipeiying identificationofpharmacokineticmarkersforsafflowerinjectionusingacombinationofsystempharmacologymulticomponentpharmacokineticsandquantitativeproteomicsstudy
AT ruanyijun identificationofpharmacokineticmarkersforsafflowerinjectionusingacombinationofsystempharmacologymulticomponentpharmacokineticsandquantitativeproteomicsstudy
AT zhongchenhui identificationofpharmacokineticmarkersforsafflowerinjectionusingacombinationofsystempharmacologymulticomponentpharmacokineticsandquantitativeproteomicsstudy
AT tenglinglin identificationofpharmacokineticmarkersforsafflowerinjectionusingacombinationofsystempharmacologymulticomponentpharmacokineticsandquantitativeproteomicsstudy
AT keliyuan identificationofpharmacokineticmarkersforsafflowerinjectionusingacombinationofsystempharmacologymulticomponentpharmacokineticsandquantitativeproteomicsstudy
AT yaohong identificationofpharmacokineticmarkersforsafflowerinjectionusingacombinationofsystempharmacologymulticomponentpharmacokineticsandquantitativeproteomicsstudy